Nrf2 activation putatively mediates clinical benefits of low-dose radiotherapy in COVID-19 pneumonia and acute respiratory distress syndrome (ARDS): Novel mechanistic considerations is a research paper published in Radiotherapy and Oncology (2021). On theSindex it has a DataRank of 0.564. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.564
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Center for Advancing Translational Sciences
Grant: 2UL1TR001409-06
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
ExxonMobil Foundation
Grant: S18200000000256
NCATS NIH HHS
Grant: UL1 TR001409
U.S. Air Force
U.S. Department of Health and Human Services
Henry M. Jackson Foundation
Air Force Office of Scientific Research
National Institutes of Health
FWCI
4.57
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals